BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  AveXis Announces New England Journal of Medicine Publication of Phase I Data of AVXS-101 Gene Replacement Therapy in Spinal Muscular Atrophy Type 1

  The NEJM publication provides detailed data as of August 7, 2017, from the Phase 1, open-label, dose-escalating study, designed to evaluate the safety and tolerability of AVXS-101 in patients with SMA Type 1.

  November 1, 2017

   · 

  11 min read
• Biotech Bay

  Tricida Announces Podium Presentation at ASN Kidney Week 2017 of TRC101 Phase I/II Study Results in Patients With Metabolic Acidosis Associated with Chronic Kidney Disease

  Tricida today announced that David A. Bushinsky, M.D., will deliver a podium presentation at the ASN Annual Kidney Week meeting, taking place November 1-5, 2017 in New Orleans, on the results of Tricida’s successful Phase 1/2 study of TRC101.

  November 1, 2017

   · 

  3 min read
• Business

  NN Reports Third Quarter 2017 Results

  Growth in the medical, aerospace and automotive end markets accounted for the increase.

  November 1, 2017

   · 

  17 min read
• Business

  DexCom Reports Record Third Quarter 2017 Financial Results

  Revenue grew to $184.6 million for the third quarter of 2017, an increase of 24% from the $148.6 million in revenue for the same quarter in 2016.

  November 1, 2017

   · 

  8 min read
• Business

  Clovis Oncology Announces Third Quarter 2017 Operating Results

  Clovis Oncology reported financial results for the quarter ended September 30, 2017, and provided an update on the Company’s clinical development programs and regulatory outlook for the remainder of 2017.

  November 1, 2017

   · 

  20 min read
• Titan Medical Announces Final Closing of CDN $3.3 Million Private Placement Led by Group of U.S. Robotic Surgeons

  Titan Medical announces, following the initial closing on October 20, 2017, the Company completed the final closing of a private placement of 13,385,900 total common shares at a price of CDN $0.25 per share for total gross proceeds of CDN $3,343,416.

  November 1, 2017

   · 

  2 min read
• Immunovia Receives SEK4.9 Million Grant From Swelife Accelerator Innovation Program

  Immunovia announced today it has received a follow-on grant of SEK4.9 million from the Swelife Accelerator Innovation Program to support the last development studies of IMMray™ PanCan-d.

  November 1, 2017

   · 

  3 min read
• Business

  Mirati Therapeutics Reports Third Quarter 2017 Financial Results

  Cash, cash equivalents, and short-term investments were $75M at September 30, 2017, compared to $56.7M at December 31, 2016.

  November 1, 2017

   · 

  10 min read
• Lexington Biosciences Comments on Recent Trading Activity

  On October 17, 2017, the Company’s management became aware of certain promotional materials that were published by Techstock Insider that were purportedly paid for by Ellis Stewart LLC.

  November 1, 2017

   · 

  4 min read
• Biotech Beach

  Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share

  This cash dividend will be distributed on Monday, November 20, to shareholders of record as of Monday, November 13, 2017.

  November 1, 2017

   · 

  2 min read